current user: public

If you have questions about the server, please let us know.

Query: 6bo8_A mol:protein length:742 Transient receptor potential cation channel subfamily V member 6, from PDB1018

Results of FFAS03 search in PDB1018
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680    .  690    .  700    .  710    .  720    .  730    .  740
# Score Template Links and tools%idFirst MGLSLPKEKGLILCLWSKFCRWFQRRESWAQSRDEQNLLQQKRIWESPLLLAAKDNDVQALNKLLKYEDCKVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVVNQNMNLVRALLARRASVSARATGTAFRRSPCNLIYFGEHPLSFAACVNSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDRHGDHLQPLDLVPNHQGLTPFKLAGVEGNTVMFQHLMQKRKHTQWTYGPLTSTLYDLTEIDSSGDEQSLLELIITTKKREARQILDQTPVKELVSLKWKRYGRPYFCMLGAIYLLYIICFTMCCIYRPLKPRTNNRTSPRDNTLLQQKLLQEAYMTPKDDIRLVGELVTVIGAIIILLVEVPDIFRMGVTRFFGQTILGGPFHVLIITYAFMVLVTMVMRLISASGEVVPMSFALVLGWCNVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPEELGHFYDYPMALFSTFELFLTIIDGPANYNVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQIVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIQRYAQAFHTRGSEDLDKDSVEKLELGCPFSPHLSLPMPSVSRSTSRSSANWERLRQGTLRRDLRGIINRGLEDGESWEYQILVPRGSAAAWSHPQFEKLast
1 -238.0006bo8_A mol:protein length:742 Transient receptor potential cation channel subfamily V member 6  ali model  100  1MGLSLPKEKGLILCLWSKFCRWFQRRESWAQSRDEQNLLQQKRIWESPLLLAAKDNDVQALNKLLKYEDCKVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVVNQNMNLVRALLARRASVSARATGTAFRRSPCNLIYFGEHPLSFAACVNSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDRHGDHLQPLDLVPNHQGLTPFKLAGVEGNTVMFQHLMQKRKHTQWTYGPLTSTLYDLTEIDSSGDEQSLLELIITTKKREARQILDQTPVKELVSLKWKRYGRPYFCMLGAIYLLYIICFTMCCIYRPLKPRTNNRTSPRDNTLLQQKLLQEAYMTPKDDIRLVGELVTVIGAIIILLVEVPDIFRMGVTRFFGQTILGGPFHVLIITYAFMVLVTMVMRLISASGEVVPMSFALVLGWCNVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPEELGHFYDYPMALFSTFELFLTIIDGPANYNVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQIVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIQRYAQAFHTRGSEDLDKDSVEKLELGCPFSPHLSLPMPSVSRSTSRSSANWERLRQGTLRRDLRGIINRGLEDGESWEYQILVPRGSAAAWSHPQFEK 742
2 -193.0006b5v_A mol:protein length:730 Transient receptor potential cation channel subfamily V member 5  ali model follow..  71  3.ACPPKAKGPWA-----QLQKLLISWPVGEQDRDRVNMLQQERIRDSPLLQAAKENDLRLLKILLLNQSCDFQQRGAVGETALHVAALYDNLEAATLLMEAAPELAKEPALCEPFVGQTALHIAVMNQNLNLVRALLARGASVSARATGAAFRRSPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDEHSDHLQSLELVPNHQGLTPFKLAGVEGNTVMFQHLMQKRKHVQWTCGPLTSTLYDLTEIDSWGEELSFLELVVSSKKREARQILEQTPVKELVSFKWKKYGRPYFCVLASLYILYMICFTTCCIYRPLKLRDDNRTDPRDITILQQKLLQEAYVTHQDNIRLVGELVTVTGAVIILLLEIPDIFRVGASRYFGQTILGGPFHVIIITYASLVLLTMVMRLTNMNGEVVPLSFALVLGWCSVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFHITFQTEDPNNLGEFSDYPTALFSTFELFLTIIDGPANYSVDLPFMYCITYAAFAIIATLLMLNLFIAMMGDTHWRVAQERDELWRAQVVATTVMLERKMPRFLWPRSGICGYEYGLGDRWFLRVENHHDQNPLRVLRYVEAFKCSDKEDGQEQLSEKRPSTVESGAFQTPSLSRTTSQSSNSHRGWEILRRNTLGHLNLGLD----EGDGEEVYHF................. 730
3 -193.0006e2g_A mol:protein length:727 Transient receptor potential cation channel subfamily V member 6  ali model follow..  85  14CLWNKFCRWF-----HRRESWAQSRDEQ--------NLLQQKRIWESPLLLAAKENNVQALIKLLKFEGCEVHQKGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGG-DHLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRKHIQWTYGPLTSTLYDLTEIDSSGDDQSLLELIVTTKKREARQILDQTPVKELVSLKWKRYGRPYFCVLGAIYVLYIICFTMCCVYRPLKPRITNRTNPRDNTLLQQKLLQEAYVTPKDDLRLVGELVSIVGAVIILLVEIPDIFRLGVTRFFGQTILGGPFHVIIVTYAFMVLVTMVMRLTNSDGEVVPMSFALVLGWCNVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPDELGHFYDYPMALFSTFELFLTIIDGPANYDVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQVVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIRRYAQAFQQQDDEDLEKDSGEKLEMARPFGAYLSFPTPSVSRSTSRSSTNWDRLRQGALRKDLQGIINRGLEDGE--------------GWEYQ.... 726
4 -173.0005wo7_A mol:protein length:676 Transient receptor potential cation channel subfamily V member 6  ali model follow..  85  10.GLILCLWNKFCRWFHRRESWAQSRDEQ--------NLLQQKRIWESPLLLAAKENNVQALYKLLKFEGCEVHQKGAMGETALHIAALYDNNEAAQVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGG-DHLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRKHIQWTYGPLTSTLYDLTEIDSSGDDQSLLELIVTTKKREARQILDQTPVKELVSLKWKRYGRPYFCVLGAIYVLYIICFTMCCVYRPLKPRITNRTNPRDNTLLQQKLLQEAYVTPKDDLRLVGELVSIVGAVIILLVEIPDIFRLGVTRFFGQTILGGPFHVIIVTYAFMVLVTMVMRLTNSDGEVVPMSFALVLGWCNVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPDELGHFYDYPMALFSTFELFLTIIDGPANYDVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQVVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIRRYAQAFQQQDDLYSEDLEKDSGEKLVPRLVPR................................................................. 676
5 -146.0006dvw_A mol:protein length:791 Transient receptor potential cation channel subfamily V member 3  ali model follow..  24  62.PIFSKPMDSNI-----RQCLSGNCDDMDSPQSAKEEQRQKKKRLKKRIFAAVSEGCVEELRELLQDLQMHKLTASDTGKTCLMKALLNNTKEIVRILLAFAEEFINAEYTEEAYEGQTALNIAIERRQGDITAVLIAAGADVNAHAKGVFFNPKQHEGFYFGETPLALAACTNQPEIVQLLMENQTDITSQDSRGNNILHALVTVAEDKTQNDFVKRMYDMILLRSGNWELETMRNNDGLTPLQLAAKMGKAEILKYILSREIKTDWAYGPVSSSLYDLTNVDTTTDNSVLEIIVYNTNIDNRHEMLTLEPLHTLLHTKWKKFAKYMFFLSFCFYFFYNITLTLVSYYRPRE---------------EDLPHPLALTHKMSWLQLLGRMFVLIWATCISVKEGIAIFLLRPSD-LQSILSDAWFHFVFFVQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYILFLLGFGVALASLIEKCDKKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSTYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRFRMGELCKDEDFRLCLRINEKWTEWKTHVSFLNEDPGPIRRTADLNKIQDSSRSNSKTTLYAFDELDEFPETS...................................................... 790
6 -143.0006c8f_A mol:protein length:675 Transient receptor potential cation channel, subfamily V, member 4  ali model follow..  27  1......................MAPSPDPPPVI--------KMFNRHMLFDIVSRGSTAELEGFLPRLTDEEFREASTGKTCLTKALMNGKNDTIPMLIDIAEKFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKEGGYFYFGELPLSLAACTNQPDIVHYLTENAADIRRQDSRGNTVLHALVAIADNTRENTKFDLLVIKCVKLYPDSSLEAIFNNDSMSPLMMAAKLGKIGIFQHIIRLEIKRDWAYGPVYSSLYDLSMLDTCGEEVSVLELVYNSKVENRHEMLAVEPINELLRDKWQKFGAVSFYISVVSYLIAMIIFTLIAYYRP-----------------MDGTPPYPYRTTMDYMRLAGEIVTLLTGVVFFITNIKDLFMKK-CPGVNSLFIDGSFQLLYFIYSVLVIITAVLYLVGIESYLAVMVFALVLGWMNALYFTRGLKLTGTYSIMLQKILFKDLFRFLLVYLLFMIGYASALVSLLNPCTSQECRDSSTFSKFLLDLFKLTIGMGDLEMINSAKYPAVFIILLVTYIILTFVLLLNMLIALMGETVGQVSKESKQIWKLQWATTILDIERSFPVCMRKAFRS-NLDGTPDRRWCFRVDENWSHWNQNLGIINEDPGRSNSLEVLFQ................................................................................ 675
7 -142.0005irx_A mol:protein length:636 Transient receptor potential cation channel subfamily V member 1  ali model follow..  27  2......................................MGSRLYDRRSIFDAVAQSNCQELESLLPRLTDSEFKDPETGKTCLLKAMLNGQNDTIALLLDVARKTDNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTGRPGFYFGELPLSLAACTNQLAIVKFLLQNSADISARDSVGNTVLHALVEVADNTVDNTMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHTEWAYGPVHSSLYDLSCIDTCENSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPV----------------EGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPS--LKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGK------YNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLDGKDDYRWCFRVDENWTTWNTNVGIINEDPG.......................................................................................... 636
8 -141.0006bwj_A mol:protein length:776 Transient receptor potential cation channel subfamily V member 2  ali model follow..  23  8.AFRLETSDG-----GQDGAEVDKAQLGNYRKGAGASQPDLNRFDRDRLFNVVARGNPEDLAGLLEYLRDSEYTEGSTGKTCLMKAVLNGVNACIQPLLEIDRDLVNAQCTDEYYRGHSALHIAIEKRSLQCVKLLVENGANVHAKACGHFFQKNQDTCFYFGELPLSLAACTKQWDVVNYLLENPASLQAQDSLGNTVLHALVMIADDSLVVRMYDGLLQAGARLCPNVQLEGIPNLEGLTPLKLAAKEGKIEIFKHILQREFSAPWCYGPVRVSLYDLASVDSWEENSVLEIIAFHSRSPHRHRMVVLEPLNKLLQAKWDRLIP-RFCFNFLCYLVYMLIFTAVAYHQP---------------ALEKQGFPPLKATAGNSMLLLGHILILLGGVYLLLGQLWYFWRRRLFIWI--SFMDSYSEILFLLQALLTVLSQVLCFLAIEWYLPLLVSSLVMGWTNLLYYTRGFQHTGIYSVMIEKVILRDLLRFLLVYLVFLFGFAVALVSLSREAQNDEAPPYRSILDASLELFKFTIGMGELAFQEQLRFRGVVLLLLLAYVLLTYVLLLNMLIALMSETVNSVATDSWSIWKLQKAISVLEMENGYWWCRRKKQRATRPDGSPDERWCFRVGENWATWEQTLPRTLCEEPSGAAAPGVMKNPTPASQRGEDSASEEDHLPLQLLQSRDYKDD................................................ 766
9 -141.0005an8_A mol:protein length:613 TRPV2  ali model follow..  27  2...............................................RLFNVVARGNPEDLAGLLEYLRDSEYTEGSTGKTCLMKAVLNGVNACIQPLLEIDRDLVNAQCTDEYYRGHSALHIAIEKRSLQCVKLLVENGANVHAKACGHFFQKNQDTCFYFGELPLSLAACTKQWDVVNYLLENAASLQAQDSLGNTVLHALVMIADNSLVVRMYDGLLQAGARLCPNVQLEGIPNLEGLTPLKLAAKEGKIEIFKHILQREFSAPWCYGPVRVSLYDLASVDSWEENSVLEIIAFHSRSPHRHRMVVLEPLNKLLQAKWDRLIPRFCF-NFLCYLVYMLIFTAVAYHQP---------------ALEKQGFPPLKATAGNSMLLLGHILILLGGVYLLLGQLWYFWRRRLFIWI--SFMDSYFEILFLLQALLTVLSQVLCFLAIEWYLPLLVSSLVLGWLNLLYYTRGFQHTGIYSVMIQKVILRDLLRFLLVYLVFLFGFAVALVSLSREAQEDEAPPYRSILDASLELFKFTIGMGELAFQEQLRFRGVVLLLLLAYVLLTYVLLLNMLIALMSETVNSVATDSWSIWKLQKAISVLEMENGYWWCRRKKQRAGVMLTSPDERWCFRVGE........................................................................................................... 612
10 -136.0003j5p_B mol:protein length:598 Transient receptor potential cation channel subfamily V member 1  ali model follow..  28  2...........................................YDRRSIFDAVAQSNCQELESLLPKRLTDSEKDPETGKTCLLKAMLNGQNDTIALLLDVARKTDNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKRPGFYFGELPLSLAACTNQLAIVKFLLQNSADISARDSVGNTVLHALVEVADNTVDNTMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHTEWAYGPVHSSLYDLSCIDTCENSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPV----------------EGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQR--RPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGK------YNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAXXXXXXXXXXXX................................................................................................................... 598
11 -134.0006mho_B mol:protein length:826 Transient receptor potential cation channel subfamily V member 3  ali model follow..  24  30.KRPAEITPT-----KKSAHFFLEIEGFEPNPTAKEEQRRKKRRLKKRIFAAVSEGCVEELVELLVELQELCRTASDTGKTCLMKALLNNTKEIVRILLAFAEEFINAEYTEEAYEGQTALNIAIERRQGDIAALLIAAGADVNAHAKGAFFNPKQHEGFYFGETPLALAACTNQPEIVQLLMEHQTDITSRDSRGNNILHALVTVAEDFKTQNFVKRMYDMILLRSGNWELETTRNNDGLTPLQLAAKMGKAEILKYILSREIKTDWAYGPVSSSLYDLTNVDTTTDNSVLEITVYNTNIDNRHEMLTLEPLHTLLHMKWKKFAKHMFFLSFCFYFFYNITLTLVSYYRPREEEAIPHPL--------------ALTHKMGWLQLLGRMFVLIWAMCISVKEGIAIFLLRPSD-LQSILSDAWFHFVFFIQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYIVFLLGFGVALASLIEKCDNKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSKYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRFGELCKVAEDDFRLCLRINEKWTEWKTHVSFLNEDPGP--VRRTDFNKIQDSSRNNSKTTLNAFEEVEEFPETSVVDAGLEVLFQGP--------AAVDYKDDDDKA.................... 816
12 -134.0006bbj_A mol:protein length:868 Transient receptor potential cation channel, subfamily V, member 4  ali model follow..  25  67IRFQGPFRKG-----ISNPMDLLESTIYESSAPKKAPMDSIKMFNRHMLFDIVSRGSTAELEGFLPRLTDEEFREASTGKTCLTKALMNGKNDTIPMLIDIAEKFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQKDEGGYFYFGELPLSLAACTNQPDIVHYLTENAADIRRQDSRGNTVLHALVAIADNTRENKVYDLLVIKCVKLYPDSSLEAIFNNDSMSPLMMAAKLGKIGIFQHIIRLEIKRDWAYGPVYSSLYDLSMLDTCGEVSVLEILVYNSKVENRHEMLAVEPINELLRDKWQKFGAVSFYISVVSYLIAMIIFTLIAYYRPMDGTPP-----------------YPYRTTMDYMRLAGEIVTLLTGVVFFITNIKDLFMKK-CPGVNSLFIDGSFQLLYFIYSVLVIITAVLYLVGIESYLAVMVFALVLGWMNALYFTRGLKLTGTYSIMLQKILFKDLFRFLLVYLLFMIGYASALVSLLNPCTSQECRDSSTFSKFLLDLFKLTIGMGDLEMINSAKYPAVFIILLVTYIILTFVLLLNMLIALMGETVGQVSKESKQIWKLQWATTILDIERSFPVCMRKAFRSGEMDGTPDRRWCFRVDENWSHWNQNLGIINEDPGRNDGYQYYGFSQTVGRLRRDRWSVVVPRVVELNKAPQHSDD--GNIPQVQTYSQRQENAQNWKKD----ETHI................. 868
13 -129.0005hi9_A mol:protein length:770 Transient Receptor Potential Cation Channel Subfamily V Member 2  ali model follow..  25  33PPMESPFQRED-----RNSSPQIKVNLNFIKRPSAPSQQEPDRFDRDRLFSVVSRGVPEELTGLLEYLTDSAYTEGSTGKTCLMKAVLNGVNACIMPLLQIDKDLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPASLEATDSLGNTVLHALVMIADNSLVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSTEWCYGPVRVSLYDLSSVDSWEKNSVLEIIAFHCKSPNRHRMVVLEPLNKLLQEKWDRLVSRFFF-NFACYLVYMFIFTVVAYHQP---------------SLDQPAIPSSKATFGESMLLLGHILILLGGIYLLLGQLWYFWRRRLFIWI--SFMDSYFEILFLLQALLTVLSQVLRFMETEWYLPLLVLSLVLGWLNLLYYTRGFQHTGIYSVMIQKVILRDLLRFLLVYLVFLFGFAVALVSLSREARSEEPAPYRSILDASLELFKFTIGMGELAFQEQLRFRGVVLLLLLAYVLLTYVLLLNMLIALMSETVNHVADNSWSIWKLQKAISVLEMENGYWWCRRKKHREGRLLKTPDERWCFRVEENWAAWEKTLPTLSEDPSGPGITGNKKNPTSKPGKNSASEEDHLPLQVLQSPTETSQVA................................................. 768
14 -73.5005vkq_A mol:protein length:1732 No mechanoreceptor potential C isoform L  ali model follow..  14  866.PLQLAAEGG-----HADVVKALVRAGASCTEENKA--------GFTAVHLAAQNGHGQVLDVLKS-TNSLRINSKKLGLTPLHVAAYYGQADTVRELLTSVPATVKSFGDLGTESGMTPLHLAAFSGNENVVRLLLNSGVQVDAATIEN--AELLQSQDRNGRTGLHIAAMHGHIQMVEILLGQGAEINATDRNGWTPLHCAAKAGHLEVVKLLCEAGASPK-----------SETNYGCAAIWFAASEGHNEVLRYLMNKEHDTYGLMEDKRFVYNLMVVSKNHNNKPIQEFVLVSPAPVDTAA--KLSNIYIVLSTKEKERAKDLVAAGKQCEAMATELLALAALQELWHGSLTWASWKILLLLVAFIVCPPVWIGFTFPMGHKFNKVPIIKFMSYLTSHIYLMIHLSIYPVLRLSLVPYWYEVGLLIWLSGLLLFIKVLVLLLGMANQCFALAFLLACVQILDFLSFHHLFGPWAIIIGDLL-KDLARFLAVLAIFVFGFSMHIVALNQSFANFSMHPINSFELLFFAVFGQTTQVDKIKNVATPTQPYLFKIVFGIYMLVSVVVLIQLLIAMMSDTYQRIQAQSDIEWKFGLSKLIRNMHRTAPSPLNLVTTWFMWIVEKVKARMKKKKRPSLVQMMGIRQASPRTKAGAKWLSKIKKDSVALSQVHLSPLGSQASFSQANQNRIENADWEAIAKKYRALVGDEEGGSLKDSDAESGSQEGSGGQQPPAQVGRRAIK 1724
15 -72.6006d7l_A mol:protein length:853 Short transient receptor potential channel 3  ali model follow..  12  14.RMTVMREKG-----RRQAVRGPAFMFNDRGTSLTA--------EEERFLDAAEYGNIPVVRKMLEEKTLNVNCVDYMGQNALQLAVGNEHLEVTELLLKKENLARIG----------DALLLAISKGYVRIVEAILNHPGFAASKRLTLYAYDEDGTRFSPDITPIILAAHCQKYEVVHMLLMKGARIERPHDYFCKCGDCMEKQRHDSFSHSRSRINAYKG-----------LASPAYLSLSSEDPVLTALELSNELAKLANKNDYRKLSMQCKDFVVGVLDLCRDSEEVEAILNGDLKYEVKKFVAHPNCQQQLLTIWREQTIAIKCLVVLVVALGLPFLAIGYWIAPCSRLGKILRSPFMKFVAHAASYPKQIFRVKTTQFTWTEMLIMVWVLGMMWSECKELWLEGPREYILQ------WNVLDFGMLSIFIAAFTARFLAFLQSEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTV-KDIFKFMVLFIMVFFAFMIGMFILYSYYLGAKVNAFTTVEESFKTLFWSIFGLSEVTSVVHKFIENIGYVLYGIYNVTMVVVLLNMLIAMINSSYQEIEDDSDVEWKFARSKLWLSYGKTLPPIMRIVNFPKCRRRRLQKDIEMGMGNSKSRLNLFTQSNSRVFESHSFNSILNQPTRYQQIMKRLIKRYVLKAQVDKENDEVNEGELKEIKQSSLRYELLEDKSQATEELAILIHKLSEKLNPSMLRCE..... 853
16 -71.6005z96_A mol:protein length:755 Short transient receptor potential channel 4  ali model follow..  14  3.QFYYKRNVNA-----PYRDRIPLRI---------VRAESELSPSEKAYLNAVEKGDYASVKKSLEEAEININCIDPLGRTALLIAIENENLELIELLLSFNVYV------------GDALLHAIRKEVVGAVELLLNHKKPSGEKQVPPILLDKQFSEFTPDITPIILAAHTNNYEIIKLLVQKGVSVPRPHEVRCNCVECVSSSDVDSLRHSRSRLNIYKALASPSLIAL------SSEDPFLTAFQLSWELQELSKVENEFKSEYEELSRQCKQFAKDLLDQTRSSRELEIILKLAIKYRQKEFVAQPNCQQLLASRWRRRHWAVKMVTCFIIGLLFPVFSVCYLIAPKSPLGLFIRKPFIKLLLASQHIDRSDLNRQGPPPTIVEWMILPWVLGFIWGEIKQMWDGGLQDYIHD------WNLMDFVMNSLYLATISLKIVAFVKYEALFAIANIFSSLRLISLFTANSHLGPLQISLGRML-LDILKFLFIYCLVLLAFANGLNQLYFYYEETKNNAFSTLFETLQSLFWSIFGLINLYVTNVKAQEFVGATMFGTYNVISLVVLLNMLIAMMNNSYQLIADHADIEWKFARTKLWMSLWYLVKWIWTHLCKKKMRRKPESFGTIGRRAADNLRRHHQYQEVMRNLVKRYVAAMIREAKTEEGLTEENVKELKQDISSFRFEVLGLLR................................................. 755
17 -70.0005yx9_A mol:protein length:931 Short transient receptor potential channel 6  ali model follow..  12  31.YLLMDSELG-----EDGCPQAPLPCYGYYPCFRGSDRSTSLSIEEERFLDAAEYGNIPVVRKMLEEHSLNVNCVDYMGQNALQLAVANEHLEITELLLKKENLSRVG----------DALLLAISKGYVRIVEAILSHPAFAEGKRLATYAYDEDGTRFSHDVTPIILAAHCQEYEIVHTLLRKGARIERPHDYFCKCNDCNQKQKHDSFSHSRSRI-----------NAYKGLASPAYLSLSSEDPVMTALELSNELAVLANKNDYKKLSMQCKDFVVGLLDLCRNTEEVEAILNGDVKYEVKKFVAHPNCQQQLLSIWRQQTMAVKFLVVLAVAIGLPFLALIYWFAPCSKMGKIMRGPFMKFVAHAASNAKQLFRMKTSCFSWMEMLIISWVIGMIWAECKEIWTQGPKEYLFE------WNMLDFGMLAIFAASFIARFMAFWHSEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTV-KDIFKFMVIFIMVFVAFMIGMFNLYSYYGAKQNEAFTTVEESFKTLFWAIFGLSEVKSVVHKFIENIGYVLYGVYNVTMVIVLLNMLIAMINSSFQEIEDDADVEWKFARAKLLVPSPKSLFYLLLKLKKWISELFQGHKKGFQEDAEMNKINEEKKLGILGSHEDLSKLSLDKKQVGHNKQPSIRSSEDFHLNSFNNPPRQYQKIMKRLIKRAQIDKESDEVNEGELKEIKQDISSLRYELLEEKSQNTEDLAE 911
18 -69.6003j9p_D mol:protein length:1528 Maltose-binding periplasmic protein, Transient receptor potential cation channel subfamily A member 1 chimera  ali model follow..  13  602.PIHQAAFSG-----SKECMEIILRFGEEHGYSRQLHINFMNNGKATPLHLAVQNGDLEMIKMCLD-NGAQIDPVEKGRCTAIHFAATQGATEIVKLMISSYSGSVDADINKIDSEGRSPLILATASASWNIVNLLLSKGAQVDIKDNFGRNKELVMDEDNDGCTPLHYACRQGGPGSVNNLLGFNVSIHSKSKDKKSPLHFAASYGRINTCQRLLQDISDTRLLNEGKKGALFLSDHNGWTALHHASMGGYTQTMKVILDTNLKCDRLDEDGNTALHFAAR---EGHAKAVALLLSHNADIV-LNKQQASFLHLALHNKRKEVVLTIIRSKRWDECLKITQDVIYEPLTALNAMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGLIPMTILVVNIKPGMAFNSTGIINEDHSEILDTTNSYLIKTCMILVFLSSIFGYCKEAGQIFQ-AIAVYFYWMNFLLYLQRFENCGIFIVMLEV-ILKTLLRSTVVFIFLLLAFGLSFYILLNLQDP-----FSSPLLSIIQTFSMMLGDINYRESFELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIADVQKHASLKRIAMQVELHTSLEKKLPLWFLRKV----------DQKSTIVYPNKPRSGGMLFHIFCFLFCTGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQH-----ELIKLIIQKMEI-------ISETEDDDSHCSFQDRFKKEQMEQRNSR 1503
19 -67.3006cv9_A mol:protein length:842 Short transient receptor potential channel 6  ali model follow..  12  1....................................AMGSMLSIEEERFLDAAEYGNIPVVRKMLEEHSLNVNCVDYMGQNALQLAVANEHLEITELLLKKENLSRVG----------DALLLAISKGYVRIVEAILNHPAFAEGKRLATSPSDEDGTRFSHDVTPIILAAHCQEYEIVHTLLRKGARIERPHDYFCKCTECSQKQKHDSFSHSRSRI-----------NAYKGLASPAYLSLSSEDPVMTALELSNELAVLANKNDYRKLSMQCKDFVVGLLDLCRNTEEVEAILNGDAETRDFGRPNLSRLKLAIKYEVKKFVAH--FLVVLAVAIGLPFLALIYWCAPCSKMGKILRGPFMKFVAHAASNARQLFRMKTSCFSWMEMLIISWVIGMIWAECKEIWTQGPKEYLFE------WNMLDFGMLAIFAASFIARFMAFWHSEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTV-KDIFKFMVIFIMVFVAFMIGMFNLYSYYGAKQNEAFTTVEESFKTLFWAIFGLSEVKSVVHKFIENIGYVLYGVYNVTMVIVLLNMLIAMINSSFQEIEDDADVEWKFARAKLWFSYGRTLPAEMNKRNEEKKFGISGSHEDLSKFSLDKNQLAHNKQSSTRSSEDYHLNSFSNPPRQYQKIMKRLIKRYVLQAQIDKESDEVNEGELKEIKQSSLRYELLEEKSQNTEDLAELIRKLGERLSLEPKLEESR... 841
20 -67.2002rfa_A mol:protein length:232 Transient receptor potential cation channel subfamily V member 6  ali model follow..  87  3............................................WESPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDH-LKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRKHIAAA......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 226
21 -64.5004dx1_A mol:protein length:259 Transient receptor potential cation channel subfamily V member 4  ali model follow..  34  2...........................................FNRPILFDIVSRGSTADLDGLLKRLTDEEFREPSTGKTCLPKALLNGRNDTIPVLLDIAERFINSPFRDIYYRGQTALHIAIERRCKHYVELLVAQGADVHAQARGRFFQPKEGGYFYFGELPLSLAACTNQPHIVNYLTENKADMRRQDSRGNTVLHALVAIADNTRENKMYDLLLLKCARLFPDSNLEAVLNNDGLSPLMMAAKTGKIGIFQHIIRREVTDEAA......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 252
22 -63.4002etc_A mol:protein length:274 Transient receptor potential cation channel subfamily V member 2  ali model follow..  32  1..............................KNTSAPSQQEPDRFDRDRLFSVVSRGVPEELTGLLEYLRDSAYTEGSTGKTCLMKAVLNLQDACIMPLLQIDKDLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPASLEATDSLGNTVLHALVMIADSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREF--SGPYQPLAAA.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 268
23 -62.9002nyj_A mol:protein length:273 Transient receptor potential cation channel subfamily V member 1  ali model follow..  32  3..................................SAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFRLTDSEFKDETGKTCLLKAMLNGQNDTIALLLDVARKTDNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSADISARDSVGNTVLHALVEVADNTVDNTMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEP........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 260
24 -62.1002f37_A mol:protein length:251 Transient receptor potential cation channel subfamily V member 2  ali model follow..  27  10.RLFNAVSRGVP-----EDLAGLPEYLSKTSKYLTDSEYTEGSTGKTCLMKAV------------------LNLKDGVNACILPLLQIDRDSGNPQPLVN-------AQCTDDYYRGHSALHIAIEKRSLQCVKLLVENGANVHARACGRFFQKGQGTCFYFGELPLSLAACTKQWDVVSYLLENPASLQATDSQGNTVLHALVMISDNSAENIMYDGLLQAGARLCPTVQLEDIRNLQDLTPLKLAAKEGKIEIFRHILQREFS............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 251
25 -60.8004b93_B mol:protein length:269 ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 27  ali model follow..  19  14.KLLRAVADG-----DLEMVRYLLEWTEEDLEDAEDTVSAADPEFCHPLCQCPKCAPAQKRLAKVPASGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANA-----GARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKDLS-------------GNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVFVVELLLLHGASVQ-----------VLNKRQRTAVDCAEQNSKIQVVPSCVASLDDVAETDRKEYVTVKIRK............................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 263
26 -60.6006g1k_A mol:protein length:921 Transient receptor potential cation channel subfamily c member 4a  ali model follow..  13  1.GSQLYFRRTD-----NSSYRDRIPLRI-------VRAESELSTQEKSYLSAVEKGDYASVKLALEEFKININCIDPLGRTALLIAIENENLEIIELLLSFNVYV------------GDALLHAIRKEVVGAVELLLNHKKPSGEKQVPPILLDKQFSDFTPDITPIILAAHTNNYEIIKMLVQKGVSVPQPHEVRCNCVECVSSSDVDSLRHSRSRLNIY------KALASPSLIALSSEDPFLTAFQLSWE--LQELSKVENEFKAEYEELSHAKDLLDQTRSSRELELILNFRDDMNLLQDEANNELARLKLAIKYRQKEFVAQKFICHTASYLTFLFLLLLASQHI-----------------------VSNNPDRQGPKPTTVEWMILPWVLGFIWTEIKQMWDGGFQDYIHDW-----WNLMDFVMNSLYLATISLKIVAYVKYEAVFAIANIFSSLRLISLFTANSHLGPLQISLGRML-LDILKFLFIYCLVLLAFANGLNQLYFYYENSENNAFSTLFETLQSLFWSIFGLISLYVTNVKA-EFVGATMFGTYNVISLVVLLNMLIAMMNNSYQHIADHADIEWKFARTKLWMSYFEELPPPFNIIPSPKSICYLITWIKVHVFKRRSKRTETFGTLGRRAAENVRLNHQYQEVLRNL-------------VKRYVAAMIRDAKTEEGLTEENFKELKQDISSFRYENRKSTRANKSDTSASDVSHPEGSLQY 781
27 -59.0003jxi_A mol:protein length:260 Vanilloid receptor-related osmotically activated channel protein  ali model follow..  33  2.........................................KVFNRPILFDIVSRGSPD-LLSFLLTHKKRLFREPSTGKTCLPKALLNGRNDTIPILLDIAEKFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGADLRRQDSRGNTVLHALVAIADNTRENTMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREI.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 249
28 -58.8001ot8_A mol:protein length:239 Neurogenic locus Notch protein  ali model follow..  19  5.PLMIAAVRGGGLDTTAQVISDLLAQGAELNATMDKT-------GETSLHLAARFARADAAKRLLD-AGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRA----TNLNARMHDGTTPLILAARLAIEGMVEDLITADADINAADNS-------------GKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANRE-----------ITDHMDRLPRDVASERLHHDIVRLLDEH................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 239
29 -58.2004n5q_A mol:protein length:257 Transient receptor potential cation channel subfamily V member 3  ali model follow..  25  6.RIFAAVSEGCV-----EELRELLQDLQDLCRRRRGLDVPDFL---MHKLTASDTGKTCLMKALL-------NINPNTKEIVRILLAFAEENDILDRFIN-------AEYTEEAYEGQTALNIAIERRQGDITAVLIAAGADVNAHAKGVFFNPKYQHEFYFGETPLALAACTNQPEIVQLLMENETDITSQDSRGNNILHALVTVAEDFKTQNFVKRMYDMILLRSGNWELETMRNNDGLTPLQLAAKMGKAEILKYILSREIK............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 250
30 -58.2002eta_A mol:protein length:256 Transient receptor potential cation channel subfamily V member 2  ali model follow..  27  5.RLFSVVSRGVP-----EELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAV------------------LNLQDGVNACIMPLLQIDKDSGNPKPLVN-------AQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPASLEATDSLGNTVLHALVMIADSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGAAA......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 250
31 -57.2002f8x_K mol:protein length:256 Neurogenic locus notch homolog protein 1  ali model follow..  19  14.PLMIASCSGGEEEDAPAVISDFIYQGASLH-------NQTDRTGETALHLAARYSRSDAAKRLLE-ASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRA----TDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDL-------------GKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRD-----------ITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRSPQLH....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 255
32 -56.7003ljn_A mol:protein length:364 hypothetical protein  ali model follow..  14  23.KIHVAARKG-----QTDEVRRLIETGVSPTIQNRF--------GCTALHLACKFGCVDTAKYLAS-VGEVHSLWH--GQKPIHLAVMANKTDLVVALVEGAKEVNEIGSHVKHCKGQTALHWCVGLGYLEMIKILVQLGASPTAKDKADETPLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKK---KAAPAVKRMKLAPSAPVRTRSRSRARSSAVS.......................................................................................................................................................................................................................................................................................................................................................................................................................................... 363
33 -56.5002qc9_A mol:protein length:210 Notch 1 protein  ali model follow..  21  1................GSVISDFIYQGASLH-------NQTDRTGETALHLAARYSRSDAAKRLLE-ASADANIQDNMGRTPLHAAVSADAQGVFQILLRNRA----TDLDARMHDGTTPLILAARLALEGMLEDLINSHADVNAVDD-------------LGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNKEETPLFLAAREGSYETAKVLLDHFANRD-----------ITDHMDRLPRDIAQERMHHDIVRLLDE................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 209
34 -56.3001oy3_D mol:protein length:282 transcription factor inhibitor I-kappa-B-beta  ali model follow..  20  12.ALHLAVIHQ-----HEPFLDFLLGFSAGHEY-----LDLQNDLGQTALHLAAILGEASTVEKLYA-AGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTC------------GRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPE-----------DGGDKLSPCSSSGSDSDSDNRDEGDEYD............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 281
35 -56.2001k3z_D mol:protein length:282 transcription factor inhibitor I-kappa-B-beta  ali model follow..  20  11TALHLAVIHQ-----HEPFLDFLLGFSAGHEY-----LDLQNDLGQTALHLAAILGEASTVEKLYAA-GAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTC------------GRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPED-----------GGDKLSPCEEEGEDEDSDNRDEGDEYD............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 281
36 -55.8006ar6_B mol:protein length:328 DLD-4 darpin  ali model follow..  17  6.KLLEAARAG-----QDDEVRILMANGADVNADDRADVNADDVHGRTPLHLAAGRGHLEIVEVL---HGADVNAPDRWGRTPLHLAAHHGHLEIVEVLLKYGADV-----NAQDKFGKTAFDISIDSGNEDLAEILQSSSEFGGGGSGGG--GSGGGGSASDLGKKLLEAARAGQDDEVRILMANGADVNATDHLGVTPLHLAAVLGHLEIVEVLLKHGADVN-----------AYDILGRTPLHLAAWRGHLEIVEVLLKYGADVNADDTSGTTPLHLAAG---EGHLEIVEVLLKYGADVNAQDKFGKTAFDISIDNGNEDLAEIL.............................................................................................................................................................................................................................................................................................................................................................................................................................. 328
37 -55.7001yyh_A mol:protein length:253 Notch 1, ankyrin domain  ali model follow..  20  13.PLMIASCSGGEEEDAPAVISDFIYQGASLH-------NQTDRTGETALHLAARYSRSDAAKRLLE-ASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRA----TDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDL-------------GKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRD-----------ITDHMDRLPRDIAQERMHHDIVRLLDLE................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 245
38 -55.7001ikn_D mol:protein length:236 PROTEIN (I-KAPPA-B-ALPHA)  ali model follow..  20  11.FLHLAIIHEEKALT-MEVIRQVKGDLAFLNFQNNL--------QQTPLHLAVITNQPEIAEALLG-AGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEP------------CNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQ-----------MLPESEDEESYDTESEFTEFTE..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 234
39 -55.7005et0_A mol:protein length:354 Espin  ali model follow..  15  40LPVHHAARSG-----KLHCLRYLVEEVA-------LPAVSRARNGATPAHDAAATGYLSCLQWLLTQGGCRVQEKDNSGATVLHLAARFGHPDVVKWLLYQGG----ANSAITTDTGALPIHYAAAKGDLPSLKLLVGHYPE------------GVNAQTNNGATPLYLACQEGHLEVTKYLVQESADPHLRAQDGMTPLHAAAQMGHNPVLVWLVS----------FADVSFSEQDHDGATAMHFAASRGHTKVLSWLLLHGAEIS-QDLWGGTPLHDAAE---NGELECCQILAVNGAGLDVRDHDGYTAADLAEFNGHTHCSRYLRTVQTL------LEHRVLSRDQSMDLEAKQLDS............................................................................................................................................................................................................................................................................................................................................................................................. 354
40 -55.5002dvw_A mol:protein length:231 26S proteasome non-ATPase regulatory subunit 10  ali model follow..  21  2........................................EGCVSNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPV-----NDKDDAGWSPLHIAASAGRDEIVKALLVKGAHVNAVNQN-------------GCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTN-----------IQDTEGNTPLHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAK-----GGLGLILKRLAEGEEAS....................................................................................................................................................................................................................................................................................................................................................................................................................................................... 230
41 -55.5001n11_A mol:protein length:437 Ankyrin  ali model follow..  19  17.PLHVASFMG-----HLPIVKNLLQRGASPNVSNVK--------VETPLHMAARAGHTEVAKYLLQ-NKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANP-----NLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSAN-----------AESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQ---EGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNA------KTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDE................................................................................................................................................................................................................................................................................................................................................ 402
42 -54.8004o60_A mol:protein length:234 ANK-N5C-317  ali model follow..  27  8.KLLEAARAG-----HDDSVEVLLKKGADINAKDNV--------GVTPLHLAAVNGHLELVKLLLE-KGADINATDLFGLTPLHFAATNGHLELVKLLLEKGADI-----NAVDDVGVTPLHFAARNGHLELVKLLLEKGADINAMDM-------------VGPTPLHFAAKNGHLELVKLLLEKDADINAEDHFGSTPLHSAAENGHLELVKLLLEKGADIN-----------ARDKFGKTPFDLAIDNGNEDIAEVLQKAARS............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 228
43 -54.7004qfv_A mol:protein length:234 ANK-N5C-281  ali model follow..  28  8.KLLEAARAG-----HDDSVEVLLKKGADINAKDNS--------GRTPLHVAALNGHLELVKLLLE-KGADINARDMFGLTPLHTAASNGHLELVKLLLEKGADI-----NARDEDGSTPLHLAASNGHLELVKLLLEKGADINAEDHS-------------GTTPLHFAAKNGHLELVKLLLEKGADINASDFSGPTPLHSAAENGHLELVKLLLEKGADIN-----------ARDKFGKTPFDLAIDNGNEDIAEVLQKAARS............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 228
44 -54.7004cym_D mol:protein length:203 ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 27  ali model follow..  18  2..................PLGSMDPSVVTPFSRDDR--------GHTPLHVAAVCGQASLIDLLVS-KGAMVNATDYHGATPLHLACQKGYQSVTLLLLHYKASA-----EVQDNNGNTPLHLACTYGHEDCVKALVYYDVE----------SCRLDIGNEKGDTPLHIAARWGYQGVIETLLQNGASTEIQNRLKETPLKCALNSKILSVME--------------AYHLSFERRQKSSEAPVQSPQRSVD.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 197
45 -54.6001ycs_B mol:protein length:239 53BP2  ali model follow..  13  7VSLPPGKRTN-----LRKTGSERIAHGMRVKF---------NPLPLALLLDSSLEGEFDLVQRIIY-EVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNV-----NAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSD----------MQTAADKCEEMEEGYTQCSQFLYGVQEKMGIMNKGVIYALWDYEPQNDDEL---PMKEGDCMTIIHREDEWWARLNDKEGYVPRNLLGLYPRIKPRQRSL.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 238
46 -54.6006by9_A mol:protein length:328 Histone-lysine N-methyltransferase EHMT1  ali model follow..  14  4.AGPPLSEDD-----KLQGAASHVPEGFDPTGPAGL--------GRPTPGLSQGPGKETLESALIA-LDSEKPKKLRFHPKQLYFSARQGELQKVLLMLVDGIDP---NFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSED-------------QRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNG----------QMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAF---SGCVDIAEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTL------KNKEGETPLQCASLNSQVWSALQMSKALQ.................................................................................................................................................................................................................................................................................................................................................................................. 325
47 -54.5004nik_A mol:protein length:230 26S proteasome non-ATPase regulatory subunit 10  ali model follow..  20  14.VCNLAYSGK-----LEELKESILADKSLATRTDQD--------SRTALHWACSAGHTEIVEFLLQ-LGVPVNDKDDAGWSPLHIAASAGRDEIVKALLGKGAQV-----NAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHY-------------EATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIY-----------IENKEEKTPLQVAKG-GLGLILKRMVEG................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 230
48 -54.2004rlv_A mol:protein length:910 Ankyrin-1, Ankyrin-2  ali model follow..  14  232.ALHIAARKD-----DTKSAALLLQNDHNADVQSKMMVNRTTESGFTPLHIAAHYGNVNVATLLLN-RGAAVDFTARNGITPLHVASKRGNTNMVKLLLDRGGQI-----DAKTRDGLTPLHCAARSGHDQVVELLLERGAPLLARTKNGLSPAPVDDVTLDYLTALHVAAHCGHYRVTKLLLDKRANPNARALNGFTPLHIACKKNRIKVMELLVKYGASIQ-----------AITESGLTPIHVAAFMGHLNIVLLLLQNGASPDVTNIRGETALHMAAR---AGQVEVVRCLLRNGALVDARAREEQTPLHIASRLGKTEIVQLLLQHMAHPDA------ATTNGYTPLHISAREGQVDVASVLLEAGAAHSLATKKGFTPLHVAAKYGSLDVAKLLLQRRAAADSAGKN-------------------------LTPLHVAAHYDNQKVALLLLEKG----LHIAAKKNQMQIASTLLNYTNIVTKQGVTPLHLASQEGHTDMVTLLLDKGANIHMSTKSGLTSLHLAAQEDKVNVADILTKHGADQDAHTKLGYTPLIVACHYGNVKMVNFLLKQGANVNAKTKNGYTPLHQAAINVLLQHG....................................................................................................................................... 821
49 -53.9005le6_A mol:protein length:324 DD_D12_09_D12  ali model follow..  21  11.KLLEAARAG-----QDDEVRILLANGADVNTADET--------GFTPLHLAAWEGHLGIVEVLLK-NGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGV-----NATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVSAQDKFGKTPRDLARLLDALKYLLLEAAREGHRDRVEKLIKAGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVN-----------ANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAM---WGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQ............................................................................................................................................................................................................................................................................................................................................................................................................................. 315
50 -53.8005y4e_A mol:protein length:277 Ankyrin-2,Ankyrin-2  ali model follow..  20  18.SLPSSQFLD-----GMNYLRYSLEGGRSLVPRG-----SGSRNGITPLHVASKRGNTNMVKLLLD-RGGQIDAKTRDGLTPLHCAARSGHDQVVELLLERGAPL-----LARTKNGLSPLHMAAQGDHVECVKHLLQHKAPVDDVTLD-------------YLTALHVAAHCGHYRVTKLLLDKRANPNARALNGFTPLHIACKKNRIKVMELLVKYGASIQ-----------AITESGLTPIHVAAFMGHLNIVLLLLQNGASPDVTNIRGETALHMAAR---AGQVEVVRCLKVVTEEVTT...................................................................................................................................................................................................................................................................................................................................................................................................................................................... 277
51 -53.4005le9_A mol:protein length:324 DD_Off7_09_3G124  ali model follow..  21  11.KLLEAARAG-----QDDEVRILMANGADVNAADNT--------GTTPLHLAAYSGHLEIVEVLLK-HGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADV-----NAMDSDGMTPLHLAAKWGYLEIVEVLLKHGADVSAQDKFGKTPRDLARLLDALKYLLLEAAREGHRDRVEKLIKAGADVNAADDVGVTPLHLAAQRGHLEIVEVLLKCGADVN-----------AADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDNIGHTPLHLAAW---AGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQ............................................................................................................................................................................................................................................................................................................................................................................................................................. 315
52 -53.4003utm_A mol:protein length:351 Tankyrase-1  ali model follow..  16  3...............FGKSALDLADPSAKAVLTGE--------YKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADV-----HAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLW-------------QFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKG-----------------------HSLLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQT------ALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGN-----EAVQQILSESTPM............................................................................................................................................................................................................................................................................................................................................... 334
53 -53.3001k1a_A mol:protein length:241 B-cell lymphoma 3-encoded protein  ali model follow..  21  12.PLHIAVVQG-----NLPAVHRLVN----LFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVT-AGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAP-GTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKS------------GRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSS-----------LKNCHNDTPLMVARSRRVIDILRGKATRPAS............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 241
54 -53.3005cea_A mol:protein length:230 Bd3460  ali model follow..  19  1....MKKSYLLAALIF---FLAGLLHGTAFAMSGK---------SSKALNEAAEQGDLAKVKNLVQKNKIDLNAQDETGMTPLMNAAMGGNLDIVKFLLSKKVNL-----ELKNNGGETALAFAVTNDAYDVAEELIKAGANVDIIVAGD-----------EGDTLFMRAAQNNKKTAESILAKNKSLINKANTLGETALFAVARYGTPADIDFLIKKGADLK-----------LKNKKGQTALDVAKEASNQDTAKALSKKKLE............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 222
55 -53.1001wg0_A mol:protein length:243 Probable 26S proteasome regulatory subunit p28  ali model follow..  20  2............................................SNYPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD--DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITN-----------QGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLG----------KSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKGAEYDLVDNKGAKAEDVAL------NEQVKKFFLNNVVDKLAAA.................................................................................................................................................................................................................................................................................................................................................................................................................................................... 235
56 -52.7005lem_A mol:protein length:326 DD_Off7_11_3G124  ali model follow..  20  11.KLLEAARAG-----QDDEVRILMANGADVNAADNT--------GTTPLHLAAYSGHLEIVEVLLK-HGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADV-----NAMDSDGMTPLHLAAKWGYLEIVEVLLKHGALVKAKDKFGKTPKDLARDNELLEKLLLEAAREGHRDRVEEFIKRGADVNAADDVGVTPLHLAAQRGHLEIVEVLLKCGADVN-----------AADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDNIGHTPLHLAAW---AGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQ............................................................................................................................................................................................................................................................................................................................................................................................................................. 317
57 -52.7005le3_A mol:protein length:317 DD_D12_09_D12  ali model follow..  21  11.KLLEAARAG-----QDDEVRILLANGADVNTADET--------GFTPLHLAAWEGHLGIVEVLLK-NGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGV-----NATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVSAQDKFGKTPGDLAGDNGNEWIALLAAAREGHREAVERAIKAGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVN-----------ANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAM---WGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQ............................................................................................................................................................................................................................................................................................................................................................................................................................. 308
58 -52.7006emk_G mol:protein length:426 Target of rapamycin complex 2 subunit AVO2  ali model follow..  11  7VRLREAIIEGNL-----LIVKRLLRRNPDLLT------NIDSENGWSSLHYASYHGRYLICVYLIQ-LGHDKHEKTFKGNTCVHLALMKGHEQTLHLLLQQFPRFI----NHRGENGRAPIHIACMNDYYQCLSLLIGVGADLWVMDTN-------------GDTPLHVCLEYGSISCMKMLLNEGEDDNVRDKGNWKPIDVAQTFEVGNIYSKVLKEVKKKGPPLGAGK-----KPSSFRTPILNAKATFE-DGPSPVLSMNSPYSLYSNNSPLPVLPRRI---STHTTSGNGGNRRSSITNPVFNPRKPTLSTDSFSSSSNSSSRLRVNSINVKTPV-ELVSESVRHSATPTSPHNNIALINRYLLPNKSNDNVRGDSQTATINDDGGGGNGGDATIGMGLRKDPDDENENKYKIKVNNGEPRRRVSLLNIPI................................................................................................................................................................................................................................................................................................................... 413
59 -52.6005leb_A mol:protein length:473 DDD_D12_06_D12_06_D12  ali model follow..  17  11.KLLEAARAG-----QDDEVRILLANGADVNTADET--------GFTPLHLAAWEGHLGIVEVLLK-NGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGV-----NATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVFAQDKFGKTPFDLARDNGN-AAALLEAARQGQRDRVEKLMANGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNA-----------NDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAM---WGHLEIVEVLLKNGADVFAQDKFGKTPFDLARDNGNEWIAKLLLRVEKLMANGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGV............................................................................................................................................................................................................................................................................................................................................... 404
60 -52.5004rly_A mol:protein length:329 Nav1.2 - AnkB chimera  ali model follow..  18  3.TVTVPIAVG-----ESDFENLNTEGSLVPRGSKSD--------SNASFLRAARAGNLDKVVEYLK-GGIDINTCNQNGLNALHLAAKEGHVGLVQELLGRGSSV-----DSATKKGNTALHIASLAGQAEVVKVLVKEGANINAQSQN-------------GFTPLYMAAQENHIDVVKYLLENGANQSTATEDGFTPLAVALQQGHNQAVAILLENDTKG---------------KVRLPALHIAARKDDTKSAALLLQNDHNVNRTTESGFTPLHIAAH---YGNVNVATLLLNRGAAVDFTARNGITPLHVASKRGNTNMVKLLLDRGGQIDA------KTRDGLTPLHCAARSGHDQVVELLKVVTEEVTT.............................................................................................................................................................................................................................................................................................................................................................................. 329
61 -52.5005le7_A mol:protein length:328 DD_D12_13_D12  ali model follow..  20  11.KLLEAARAG-----QDDEVRILLANGADVNTADET--------GFTPLHLAAWEGHLGIVEVLLK-NGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGV-----NATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVNAQDKFGKTPEDLAKDKEDLDRKLLEAARAGHRDEVEDLIKNGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVN-----------ANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAM---WGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQ............................................................................................................................................................................................................................................................................................................................................................................................................................. 319
62 -52.5005aar_A mol:protein length:185 POTASSIUM CHANNEL AKT1  ali model follow..  23  3..............................................LNLCFAAIREDDLLLHQLLK-RGLDPNESDNNGRTPLHIAASKGTLNCVLLLLEYHADP-----NCRDAEGSVPLWEAMVEGHEKVVKVLLEHGSTIDAGDVGHF---------------ACTAAEQGNLKLLKEIVLHGGDVTRPRATGTSALHTAVCEENIEMVKYLLEQGADVNK-----------QDMHGWTPRDLAEQQGHEDIKALFRE................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 185
63 -52.4005le4_A mol:protein length:326 DD_D12_11_D12  ali model follow..  20  11.KLLEAARAG-----QDDEVRILLANGADVNTADET--------GFTPLHLAAWEGHLGIVEVLLK-NGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGV-----NATDVIGTAPLHLAAMWGHLEIVEVLLKNGALVKAKDKFGKTPKDLARDNELLEKLLLEAAREGHRDRVEEFIKRGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVN-----------ANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAM---WGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQ............................................................................................................................................................................................................................................................................................................................................................................................................................. 317
64 -52.3004uuc_A mol:protein length:226 ANKYRIN REPEAT AND SOCS BOX PROTEIN 11  ali model follow..  19  7.PLHEAAAQG-----RLLALKTLIAQGVNVNLVTIN--------RVSSLHEACLGGHVACAKALLE-NGAHVNGVTVHGATPLFNACCSGSAACVNVLLEFGAKAQLEV------HLASPIHEAVKRGHRECMEILLANNVNIDHEVPQ-------------LGTPLYVACTYQRVDCVKKLLELGASVD-HGQWLDTPLHAAARQSNVEVIHLLTDYGANLK-----------RRNAQGKSALDLAAPKSSVEQALLLREGPPAL............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 226
65 -52.3005jhq_A mol:protein length:482 Tankyrase-1  ali model follow..  15  52.PLHFAAGFG-----RKDVVEHLLQMGANVHARDDG--------GLIPLHNACSFGHAEVVSLLLC-QGADPNARDNWNYTPLHEAAIKGKIDVCIVLLQHGADPNIVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKG-------------GLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRSLLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVTELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDTLGQT------ALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGNE-----AVQQILSESTPI............................................................................................................................................................................................................................................................................................................................................... 478
66 -52.3003ui2_A mol:protein length:244 Signal recognition particle 43 kDa protein, chloroplastic  ali model follow..  17  3VNKIIGSRTAGWKDGHSPSWVPSSYIAADVVSE-----------YETPWWTAARKADEQALSQLLE--DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRG----GLTALHMAAGYVRPEVVEALVELGADIEVEDERGLTAAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVFEYAEVDEKGKDVEYLVRWKDGGDCEWVKGVHVAEDVA-------------KDYEDGLEYAVAESVI......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 243
67 -52.2005lw1_A mol:protein length:326 DD_232_11_D12  ali model follow..  20  11.KLLEAARAG-----QDDEVRILMANGADVNASDQL--------GITPLHLVAITGHLEIVEVLLK-NGADVNAHDFVGTTPLHLAAFLGHLEIVEVLLKYGADV-----NAVDRDGLTPLHLAAIHGHLEIVEVLLKHGALVKAKDKFGKTPKDLARDNELLEKLLLEAAREGHRDRVEEFIKRGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVN-----------ANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAM---WGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQ............................................................................................................................................................................................................................................................................................................................................................................................................................. 317
68 -52.2005h76_A mol:protein length:201 DARPin,Immunoglobulin G-binding protein A  ali model follow..  26  1.......................................GSHMDLGRKLLEAARAGQDDEVRILMA-NGADVNAADNTGTTPLHLAAYSGHLEIVEVLLKHGADV-----DASDVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAMDS-------------DGMTPLHLAAKWGYLEIVEVLLKHGA-VNAQDKFGKTAFDISIDNGNEDLAQILAFYEIL-----------LPNLNEEQRNAFIQSLKDDPSQSANLLAEAKKLNDAQ......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 200
69 -52.2003eu9_A mol:protein length:240 Huntingtin-interacting protein 14  ali model follow..  16  1....................................HMTHIDDYSTWDIVKATQYGIYERCRELVE-AGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVD----QLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGE-------------GCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSDPTRLLLTFNVSVNLGD----------KYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAKQ---RKNVWMINHLQEARQAKGYDN.................................................................................................................................................................................................................................................................................................................................................................................................................................................... 240
70 -52.1005w7i_A mol:protein length:239 Palmitoyltransferase ZDHHC17  ali model follow..  23  15.DIVKATQYG-----IYERCRELVEAGYDVRQPDKE--------NVTLLHWAAINNRIDLVKYYIS-KGAIVDQLGGDNSTPLHWATRQGHLSMVVQLMKYGADP-----SLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQN-------------GMTPLMWAAYRTHVDPTRLLLTFNVSVNLGDKHKNTALHWAVLAGNTTVISLLLEAGANVD-----------AQNIKGESALDLAKQRKNVWMINHLQEARQA............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 238
71 -52.1005ma5_A mol:protein length:302 K11  ali model follow..  20  9.KLLEAARAG-----QDDEVRILMANGADVNAADDV--------GVTPLHLAAQRGHLEIVEVLLK-YGADVNAADLWGQTPLHLAATAGHLEIVEVLLKNGADV-----NARDNIGHTPLHLAAWAGHLEIVEVLLKYGADVNAQDKF-------------GKTPFDLAIDNGNEDIAEVLQKGGGDVNAYDEVGWTPLHKAA-WGHLEKVEDLLKNGADVN-----------AADIDGYTPLHLAAFSGHLEIVEVLLKYGADVNADDQAGFTPLHLAAI---FGHLEIVEVLLKNGADVNAQDKFGKTPFDLAIDNGNEDIAEILQ............................................................................................................................................................................................................................................................................................................................................................................................................................. 299
72 -51.8003d9h_A mol:protein length:285 cDNA FLJ77766, highly similar to Homo sapiens ankyrin repeat and SOCS box-containing 9 (ASB9), transcript variant 2, mRNA  ali model follow..  18  24.GMDGSKPAG-----PRDFPGIRLLSNPLMG---------DAVSDWSPMHEAAIHGHQLSLRNLIS-QGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQV-----NGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPESD--------------LASPIHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVNQ------------GKGQDSPLHAVVRTASEELACLLMDFGADTQAKNAEGKRPVELVPP----ESPLAQLFLEREGASLPKPK.................................................................................................................................................................................................................................................................................................................................................................................................................................................... 278
73 -51.7006f5e_A mol:protein length:325 DD_D12_10_47  ali model follow..  20  11.KLLEAARAG-----QDDEVRILLANGADVNTADET--------GFTPLHLAAWEGHLGIVEVLLK-NGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGV-----NATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVNAQDKFGKTPYDLATKRAALRRKLLEAARAGHRDEVEDLIKNGADVNAIDAMGLTPLHLAAMRGHLEIVEVLLKYGADVNA-----------EDYYGTTPLRLAAYIGHLEIVEVLLKYGADVNAYDISGTTPLHLAAV---LGHLEIVEVLLKYGADVNAQDKFGKTAFDISIDNGNEDLAEILQ............................................................................................................................................................................................................................................................................................................................................................................................................................. 316
74 -51.7004k5c_A mol:protein length:183 Loop Designed Ankyrin Repeat Protein Nran1_G06_C  ali model follow..  28  1.......................................................................MRGSGSDLGKKLLEAAWQGQDDEVRILMANGADV-----NAQDKFGTTPLHLAADMGHLEIVEVLLKTGADVNAAATGHYFQPYFSHSVYFGETPLHLAAEMGHLEIVEVLLKAGADVNAFADLGHTPLHLAAQWGHLEIVEVLLKHGADVN-----------AQDKFGKTPFDLAIDNGNEDIAEVLQKAA............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 177
75 -51.6005lea_A mol:protein length:327 DD_Off7_12_3G124  ali model follow..  20  11.KLLEAARAG-----QDDEVRILMANGADVNAADNT--------GTTPLHLAAYSGHLEIVEVLLK-HGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADV-----NAMDSDGMTPLHLAAKWGYLEIVEVLLKHGAAVGAQDKFGKTPKDLARDNKDLRRKLLEAARAGHREEVEKLIKLGADVNAADDVGVTPLHLAAQRGHLEIVEVLLKCGADVN-----------AADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDNIGHTPLHLAAW---AGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQ............................................................................................................................................................................................................................................................................................................................................................................................................................. 318

FFAS is supported by the NIH grant R01-GM087218-01
1 3 7 8 0 7   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Sasin JM, Godzik A, Bujnicki JM. SURF'S UP! - protein classification by surface comparisons. J Biosci. 2007 Jan;32(1):97-100.